Vicente Furió

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Joan Albanell, Antonio González, Manuel Ruíz‐Borrego et al. · Annals of Oncology · 2011 · 120 citations · Full text

Medicine, Oncology, Breast Oncology +10

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

Miguel Martín, Aleix Prat, Álvaro Rodríguez-Lescure et al. · Breast Cancer Research and Treatment · 2013 · 102 citations · Full text

Medicine, Oncology, Pharmacology +17

Ultrasonographic autopsy (echopsy): a new autopsy technique

Juliana Fariña, Concepción Millana, Jesús M. Fdez-Aceñero et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2002 · 79 citations

Medicine, Pathology, Radiology +13

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

Miguel Martín, Atocha Romero, Maggie C.U. Cheang et al. · Breast Cancer Research and Treatment · 2011 · 72 citations · Full text

Medicine, Genetics, Oncology +16

Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients

Atocha Romero, José Á. García-Sáenz, Manuel Fuentes et al. · Annals of Oncology · 2012 · 67 citations · Full text

Medicine, Oncology, Breast Oncology +12